Yamaguchi Isao, Hayashi Hiroyuki, Suzuki Masayuki, Ichikawa Katsuhiro, Kidoya Eiji, Kimura Hirohiko
Radiological Center, University of Fukui Hospital, Yoshida, Fukui, Japan.
Radiat Med. 2008 Jun;26(5):278-86. doi: 10.1007/s11604-008-0228-9. Epub 2008 Jul 27.
The present study was performed to identify the theoretical background for optimal use of the bolus tracking system by analyzing the changes in the initial slope of the aortic time-enhancement curve (TEC).
We calculated the contrast medium aortic arrival time (TAR), the time to reach the trigger threshold (effective TAR), the slope of the linear equation of the enhancement unit (enhancement rate), and the time to peak aortic enhancement from the TECs of the pharmacokinetic analysis and retrospective clinical study.
In the pharmacokinetic analysis, the enhancement rate-simulated under conditions of injection duration 30 s and iodine load per body weight 500 mg/kg-was 27.1 HU/s. In the clinical study, the enhancement rate was 27.9 +/- 3.0 HU/s. A correlation was found between the TAR and the enhancement rate, indicating that enhancement rates decrease with increasing TAR. It took 22.7 +/- 0.5 s to reach maximum enhancement of the aorta from the trigger threshold of an increase of 100 HU and injection duration at 30 s.
We found that cardiac output differences are strongly dependent on the TAR and that most of the differences disappeared during the phase until effective TAR.
本研究旨在通过分析主动脉时间增强曲线(TEC)初始斜率的变化,确定团注追踪系统最佳使用的理论背景。
我们从药代动力学分析和回顾性临床研究的TEC中计算了造影剂主动脉到达时间(TAR)、达到触发阈值的时间(有效TAR)、增强单位线性方程的斜率(增强率)以及主动脉增强峰值时间。
在药代动力学分析中,注射持续时间30秒且每体重碘负荷500mg/kg条件下模拟的增强率为27.1HU/s。在临床研究中,增强率为27.9±3.0HU/s。发现TAR与增强率之间存在相关性,表明增强率随TAR增加而降低。从增加100HU的触发阈值和30秒的注射持续时间开始,主动脉达到最大增强需要22.7±0.5秒。
我们发现心输出量差异强烈依赖于TAR,并且在达到有效TAR之前的阶段,大多数差异消失。